Conference Coverage: SABCS 2022

Expert perspectives and strategic insights on the latest therapeutic developments in breast cancer treatment.

December 13, 2022


Adam Brufsky, MD, PhD

UPMC Hillman Cancer Center, Pittsburgh, PA, USA

Faculty Members

Mark Pegram, MD
Stanford Cancer Institute, Stanford, CA, USA

Mary Cianfrocca, DO, MBA
City of Hope Comprehensive Cancer Center,  Duarte, CA, USA

Joyce A. O’Shaughnessy, MD
Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX, USA

Priyanka Sharma, MD
University of Kansas Medical Center,  Kansas City, KS, USA

Peter Beitsch, MD
Dallas Surgical Group, Dallas, TX, USA

Pat Whitworth, MD, FACS, FSSO 
Nashville Breast Center, Nashville, TN, USA

Peter Kaufman, MD
University of Vermont Cancer Center, Burlington, VT, USA

Javier Cortes, MD, PhD
Vall d’Hebron University Hospital, Barcelona, Spain

Guy Jerusalem, MD, PhD
Centre Hospitalier Universitaire, Liège, Belgium

Giuseppe Curigliano, MD, PhD
Istituto Europeo di Oncologia, Milan, Italy

Sample Report

Start discovering the insights

View Report


  • Advancing Therapy for Metastatic HER2+ Breast Cancer
  • Other Novel Endocrine Strategies for ER+ Breast Cancer
  • ER+ Breast Cancer – Targeting CDKs
  • Targeting Triple-Negative Breast Cancer
  • Biomarkers and Tailored Therapy
  • Other Novel Therapeutic Approaches for Breast Cancer

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.